Skip to content
Skip to search
Skip to footer
- BACKBEAT- BradycArdia paCemaKer with AV interval modulation for Blood prEssure treAtmenT. Daniel Cooper, MD. Orchestra Biomed.
CURRENTLY ENROLLING
view on clinicaltrials.gov
- CNCR REGISTRY: A multi-center registry looking at patient outcomes for patients treated with cardiac radioablation. Pamela Samson, MD. Washington University.
- LIBREXIA-AF: A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active-Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation. Marye Gleva MD. Washington University.
IN FOLLOW-UP
view on clinicaltrials.gov
- RADIATE-VT: A study evaluating the safety and efficacy of cardiac radioablation compared to catheter ablation in patients with ventricular tachycardia. Daniel Cooper, MD. Varian Medical Systems.
CURRENTLY ENROLLING
view on clinicaltrials.gov
- REACT AF- Rhythm Evaluation for AntiCoagulaTion with Continuous Monitoring of Atrial Fibrillation. Thomas Maddox, MD. Federal Grant/Northwestern.
CURRENTLY ENROLLING
view on clinicaltrials.gov
- VIBRANT-AF: Volunteers to Investigate Best Results for Ablation and Novel Therapies for Atrial Fibrillation. Daniel Cooper MD. Washington University.
CURRENTLY ENROLLING
view on clinicaltrials.gov